Leading Companies Operating in the Global Organ Preservation Market:
# Paragonix Technologies (US)
# XVIVO Perfusion AB (Sweden)
# Dr. Franz Köhler Chemie GmbH
# Essential Pharmaceuticals, LLC
# Transmedics (US)
Major Growth Driving Factors:
The growth of the organ preservation market is mainly driven by the increasing incidence of multi-organ failure, the growing geriatric population, the rising number of organ transplants and organ donors, and increasing initiatives to encourage organ donations. However, the high cost of organ transplantations and religious concerns in specific geographies are expected to limit market growth to a certain extent.
Projected Surge in Revenue Generation, Globally:
The global organ preservation market is projected to reach USD 317 million by 2026 from USD 230 million in 2021, at a CAGR of 6.6%.
Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=261269915
Role of Leading Companies in Global Growth:
XVIVO Perfusion AB (Sweden) is a prominent player in the market and a public domain company. It is headquartered in Sweden and conducts operations in Europe, Asia, the Middle East, and North & South America. It spends nearly 31% of its revenue on R&D as a result of which the company is involved in developing improved products for organ perfusion. XVIVO’s lung perfusion solution is used mainly in Lung Preservation, making the solution a gold standard for lung preservation. In September 2020, XVIVO Perfusion entered into an acquisition agreement with Organ Assist. This agreement further strengthened the company’s product offerings and expanded its addressable market.
Paragonix Technologies (US) is the leading market player for their organ preservation and transport devices. It operates mainly in the US and Europe. The company is focused in developments such as new product launches, partnerships, agreements and approvals since 2016. The company has developed devices for all major thoracic and abdominal organ preservation and transport. Paragonix also focuses on software services and tools for real-time organ tracking.
The company recently launched a new organ transport device Sherpapak Pancreas Transport System. Paragonix also partnered with Lung Transplant Foundation to develop a series of technologies to improve donor lung preservation. In January 2021, the company partnered with Southwest Transplant Alliance (STA) to provide advanced organ preservation technologies. Such development proves the strong market prevalence of the company.
Dr. Franz Kohler Chemie GMBH (Germany) is another market leader of organ preservation solutions since 1959. It is involved in the development of electrolyte solutions, organ-protective solutions, therapeutics, antidotes, and X-ray contrast agents and medical devices. It has captured the market for Custodial, an organ preservation solution. Custodial holds advantages over other solutions like reduced viscosity and an improved graft survival rate and is widely used for the preservation of all organs unlike other solutions. Due to these advantages of a Custodial solution for organ preservation, it proves that Dr. Franz Kohler Chemie GMBH holds a substantial market prevalence.
Broader Outlook of This Research Study -
This Report Will Help You:
# To define, describe, and forecast the organ preservation market based on solution, technique, organ type, end user, and region.
# To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges).
# To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall organ preservation market.
# To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players.
# To estimate the market size and growth potential of the market segments with respect to five key regions-North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
# To profile the key players operating in the organ preservation market and comprehensively analyze their revenue shares and core competencies.
# To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, expansions, joint ventures, and acquisitions in the organ preservation market.
# To benchmark players in the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business strategy and product offering.
Get Sample Pages to Know More Details@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=261269915
The organ transplant centers segment accounted for the largest share of the organ preservation market in 2020
Based on end user, the market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment accounted for the largest share of the market in 2020. The increasing number of transplant centers across the globe is the key factor driving the acceptance of this end-user segment and propelling the market growth.
Get More Information About Related Topics:
Human Organoids Market - Emerging Trends & Global Forecast to 2025
Biopreservation Market - Emerging Trends & Global Forecast to 2025
Cardiac Monitoring Devices Market - Emerging Trends & Global Forecast to 2025
Electrophysiology Market - Emerging Trends & Global Forecast to 2027
No comments:
Post a Comment